Prestige Consumer [PBH] vs Zoetis [ZTS] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Prestige Consumer Healthcare Inc. wins in 9 metrics, Zoetis Inc. wins in 11 metrics, with 0 ties. Zoetis Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Prestige Consumer Healthcare Inc. Zoetis Inc. Better
P/E Ratio (TTM) 15.18 19.58 Prestige Consumer Healthcare Inc.
Price-to-Book Ratio 1.49 15.04 Prestige Consumer Healthcare Inc.
Debt-to-Equity Ratio 59.00 279.59 Prestige Consumer Healthcare Inc.
PEG Ratio -0.75 2.81 Zoetis Inc.
EV/EBITDA 10.24 13.96 Prestige Consumer Healthcare Inc.
Profit Margin (TTM) 16.90% 28.24% Zoetis Inc.
Operating Margin (TTM) 29.10% 34.69% Zoetis Inc.
EBITDA Margin (TTM) 29.10% 34.69% Zoetis Inc.
Return on Equity 10.31% 65.99% Zoetis Inc.
Return on Assets (TTM) 6.13% 15.26% Zoetis Inc.
Free Cash Flow (TTM) $243.29M $2.28B Zoetis Inc.
Dividend Yield N/A 1.21% N/A
1-Year Return -44.52% -53.93% Prestige Consumer Healthcare Inc.
Price-to-Sales Ratio (TTM) 2.51 5.26 Prestige Consumer Healthcare Inc.
Enterprise Value $3.74B $56.75B Zoetis Inc.
EV/Revenue Ratio 3.39 6.00 Prestige Consumer Healthcare Inc.
Gross Profit Margin (TTM) 55.52% 70.17% Zoetis Inc.
Revenue per Share (TTM) $23 $21 Prestige Consumer Healthcare Inc.
Earnings per Share (Diluted) $3.79 $6.02 Zoetis Inc.
Beta (Stock Volatility) 0.47 0.97 Prestige Consumer Healthcare Inc.
Short % of Float 8.04% 4.06% Zoetis Inc.

Prestige Consumer Healthcare Inc. vs Zoetis Inc. Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Prestige Consumer Healthcare Inc.-0.85%-4.56%-17.14%-33.12%-23.22%-25.14%
Zoetis Inc.1.51%-4.46%-31.75%-39.76%-38.95%-38.30%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Prestige Consumer Healthcare Inc.-44.52%-18.75%-4.94%-11.39%281.46%345.87%
Zoetis Inc.-53.93%-54.80%-55.66%62.09%150.53%150.53%

Performance & Financial Health Analysis: Prestige Consumer Healthcare Inc. vs Zoetis Inc.

MetricPBHZTS
Market Information
Market Cap i$2.78B$49.75B
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i403,6772,727,710
90 Day Avg. Volume i517,8763,835,940
Last Close$45.44$167.10
52 Week Range$42.62 - $87.12$139.70 - $200.33
% from 52W High-47.84%-16.59%
All-Time High$90.04 (Mar 10, 2025)$249.27 (Dec 27, 2021)
% from All-Time High-49.53%-32.96%
Growth Metrics
Quarterly Revenue Growth-0.02%0.03%
Quarterly Earnings Growth-0.24%0.04%
Financial Health
Profit Margin (TTM) i0.17%0.28%
Operating Margin (TTM) i0.29%0.35%
Return on Equity (TTM) i0.10%0.66%
Debt to Equity (MRQ) i59.00279.59
Cash & Liquidity
Book Value per Share (MRQ)$38.66$7.84
Cash per Share (MRQ)$1.32$5.48
Operating Cash Flow (TTM) i$276.63M$2.90B
Levered Free Cash Flow (TTM) i$207.17M$1.79B
Dividends
Last 12-Month Dividend Yield iN/A1.21%
Last 12-Month Dividend i$0.00$2.03

Valuation & Enterprise Metrics Analysis: Prestige Consumer Healthcare Inc. vs Zoetis Inc.

MetricPBH (Apr 24, 2026)ZTS (Apr 13, 2026)
Price Ratios
P/E Ratio (TTM) i15.1819.58
Forward P/E i11.9615.61
PEG Ratio i-0.752.81
Price to Sales (TTM) i2.515.26
Price to Book (MRQ) i1.4915.04
Market Capitalization
Market Capitalization i$2.78B$49.75B
Enterprise Value i$3.74B$56.75B
Enterprise Value Metrics
Enterprise to Revenue i3.396.00
Enterprise to EBITDA i10.2413.96
Risk & Other Metrics
Beta i0.470.97
Book Value per Share (MRQ) i$38.66$7.84

Financial Statements Comparison: Prestige Consumer Healthcare Inc. vs Zoetis Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricPBH (2025)ZTS (2025)
Revenue/Sales i1.14B9.47B
Cost of Goods Sold i503.30M2.67B
COGS % of Revenue i44.2%28.2%
Gross Profit i634.46M6.80B
Gross Margin i55.8%71.8%
Research & Development iN/A698.00M
Operating Income (EBIT) i349.24M3.60B
Operating Margin i30.7%38.0%
EBITDA i374.46M4.17B
EBITDA Margin i32.9%44.1%
Pre-Tax Income i284.19M3.36B
Pre-Tax Income % of Revenue i25.0%35.5%
Income Tax i69.58M687.00M
Income Tax % of Revenue i6.1%7.3%
Net Income (Profit) i214.61M2.67B
Profit Margin i18.9%28.2%

Balance Sheet & Liquidity Metrics

MetricPBH (2025)ZTS (2025)
Cash & Equivalents i97.88M2.31B
Total Current Assets i448.33M6.77B
Total Current Assets % of Revenue i39.4%71.5%
Total Current Liabilities i106.62M2.24B
Total Current Liabilities % of Revenue i9.4%23.6%
Long-Term Debt i1.04B9.24B
Long-Term Debt % of Revenue i91.0%97.6%
Total Shareholders Equity i1.83B3.33B
Retained Earnings i1.56B13.74B
Retained Earnings % of Revenue i136.7%145.2%
Property, Plant & Equipment i53.29M288.00M

Cash Flow Statement Comparison

MetricPBH (2025)ZTS (2025)
Operating Cash Flow i227.18M2.78B
Operating Cash Flow % of Revenue i20.0%29.3%
Capital Expenditures i-8.22MN/A
Free Cash Flow i243.29M2.28B
FCF Margin i21.4%24.1%
Debt Repayment i-139.54M-1.35B
Common Stock Repurchase i-51.51M-3.24B

Short Interest & Institutional Ownership Analysis

MetricPBHZTS
Shares Short i2.69M15.12M
Short Ratio i5.783.60
Short % of Float i8.04%4.06%
Shares Outstanding i47.32M424.93M
Float Shares i46.75M421.29M
% Held by Insiders i1.30%0.15%
% Held by Institutions i111.41%101.50%
% Held by Public i-12.71%-1.65%

Dividend Analysis & Yield Comparison: Prestige Consumer Healthcare Inc. vs Zoetis Inc.

MetricPBHZTS
Last 12-Month Dividend i$0.00$2.03
Last 12-Month Dividend Yield iN/A1.21%
3-Year Avg Annual Dividend i$0.00$1.80
3-Year Avg Dividend Yield iN/A0.29%
3-Year Total Dividends i$0.00$5.39
Ex-Dividend DateN/AJan 20, 2026